A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
Luca Lanino(Humanitas University), Vladan Vučinić(University Hospital Leipzig), Marie Robin(Universität Hamburg), David Quintela(Institut Català d'Oncologia), Ilaria Carola Casetti(ASST Fatebenefratelli Sacco), Anthony M. Hunter(Emory University), Elisabetta Sauta(IRCCS Humanitas Research Hospital), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Elisa Diral(Vita-Salute San Raffaele University), Guillermo Montalban‐Bravo(The University of Texas MD Anderson Cancer Center), Erica Travaglino(Policlinico San Matteo Fondazione), Álex Bataller(The University of Texas MD Anderson Cancer Center), Massimo Bernardi(Vita-Salute San Raffaele University), Anne Sophie Kubasch(Leukemia and Lymphoma Society), Claudia Sala, Daniele Dall’Olio, Manja Meggendorfer(Université Paris-Sud), Claude‐Eric Bulabois(Centre Hospitalier Universitaire de Grenoble), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Cristina Castilla‐Llorente(Institut Gustave Roussy), Guillermo Sanz(Instituto de Salud Carlos III), Lisa Pleyer(Paracelsus Medical University), Laëtitia Souchet(Sorbonne Université), Marisa Calabuig(Hospital Clínico Universitario de Valencia), Nico Gagelmann(Universität Hamburg), Carmelo Gurnari(University of Rome Tor Vergata), Alexandre Bazinet(Jewish General Hospital), Francesco Onida(Peter MacCallum Cancer Centre), Lee‐Yung Shih(Chang Gung University), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Esperanza Such(Leitat Technological Center), Antonio Curti(University of Bologna), Alejandro Pita(Instituto de Investigación Biomédica de Salamanca), Marina Díaz‐Beyá(Hospital Clínic de Barcelona), Klaus Geißler(University of Vienna), Hussein Awada(Cleveland Clinic), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Tamanna Haque(Memorial Sloan Kettering Cancer Center), Lurdes Zamora(Universitat Autònoma de Barcelona), Andrés Jerez(Cleveland Clinic), Verónica Roldán(Hospital de Cruces), Laura Palomo(Fundación Josep Carreras Contra la Leucemia), Lorenzo Dall'Olio(University of Bologna), Paloma García Martín(Instituto de Investigación Biosanitaria de Granada), Estefania Cerezo Velasco(Consorci Sanitari de Terrassa), Elena Cornejo(Instituto de Investigación Biosanitaria de Granada), Lorenza Borin(Azienda Ospedaliera San Gerardo), Yu‐Hung Wang(University of Manchester), Dolly Viviana Fiallo Suarez(Hospital Universitario de Gran Canaria Doctor Negrín), Francesco Passamonti(University of Insubria)
Cited by 3
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k